Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma.
Jensen
Hanne Krogh
HK
Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark. hkrje@as.aaa.dk
Nordsmark
Marianne
M
Donskov
Frede
F
Marcussen
Niels
N
von der Maase
Hans
H
D000951:Antigens, Neoplasm / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000071231:Carbonic Anhydrase IX; D002256:Carbonic Anhydrases / Q000378:metabolism*; D002292:Carcinoma, Renal Cell / Q000201:enzymology* / Q000473:pathology / Q000628:therapy; D017322:Clinical Trials, Phase II as Topic; D015331:Cohort Studies; D006801:Humans; D007150:Immunohistochemistry; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000201:enzymology* / Q000473:pathology / Q000628:therapy; D009392:Nephrectomy; D011446:Prospective Studies; D012189:Retrospective Studies; D016896:Treatment Outcome
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D007376:Interleukin-2; C089226:CA9 protein, human; D000071231:Carbonic Anhydrase IX; D002256:Carbonic Anhydrases